The Drug Controller General of India (DCGI), India's drug regulator, approved the emergency use of CoviShield and Covaxin on January 3, following the recommendations of the Subject Expert Committee (SEC). The results of Covishield's Phase-3 trials have come, but Covaxin's Phase-3 trials are ongoing.
Coveshield is co-created by Oxford University and AstraZeneca. It is being built in India by the Serum Institute of India (SII) of Adar Poonawala, Pune. At the same time, covaxin is an indigenous vaccine, which Bharat Biotech has created in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). Its phase-3 trials are going on.
The way the drug regulator has given emergency approval to both these vaccines, questions are being raised. The biggest question is about Covaxine, whose trial data is not available, that is, no one knows how effective this vaccine is. Experts say transparency was not maintained in the emergency approval process. Let's understand what is the objection of the experts and what does the government have to say on that?
What is the basis of emergency approval?
Drug Controller General of India VG Somani had said that we will not approve any vaccine which will have little safety concern. Both these vaccines are 110% safe. Side effects such as mild fever, pain, and allergies are caused by the vaccine.
Similar claims are also made by the members of the National Taskforce on the Covid-19. He claims that approval given to Covaxin is different from Covishield. AIIMS-Delhi director Dr. Randeep Guleria said that covaxin will be used as a back-up.
According to Dr. Guleria, till the final data of Bharat Biotech comes, the Covishield will be installed. Those who will apply Covaxin will take their consent. Will be monitored. It will be like clinical trials. When the final data of Covaxin arrives, it will also be allowed as Covishield.
Dr. Balaram Bhargava, Head of ICMR, says that we have done a lot of work at NIV, Pune for Covaxin's affixation data. Bronchoscopy was performed on monkeys for 14 days. The symptoms were seen every day and the effect of the vaccine was seen.
He says that Phase-1 trials of Covaxin consisted of 375 volunteers and Phase-2 consisted of 380 volunteers. Neither phase showed any serious side-effects. So far 23 thousand volunteers have been given the first dose under Phase-3 trials. But there are no concerns related to safety.
According to Dr. Bhargava, the entire virus has been targeted through covaxin. Other vaccines target the spike protein of the virus. In such a situation, the ability of covaxin against new strains has been important in its approval. This strain has now arrived in 34 countries. Because of this, it is extremely important to stop it.
What kind of questions are being raised on the vaccine approval process?
There are four main objections to the decision of India's Drug Regulator, DCGI -
1. Reliability: According to Dr. Anant Bhan, former president of the International Association of Bio-Ethics, only China and Russia have approved the vaccine before the results of Phase-3 trials. India has done the same. This puts the reliability of the regulatory process at bay.
2. Rule: Malina Isola of All India Drug Action Network says that under which rule the vaccine has been approved, it has not been given any information. The conditions related to the vaccine are also not mentioned.
3. Transparency: Epidemiologist Giridhar Babu says that if the use of covaxin will still be similar to clinical trials, what will be the process of getting consent? Have not answered any such questions.
4. Security data: Dr. Amar Jessani, editor of the Indian Journal of Medical Ethics, said the SEC has not presented any data on the issue of approving covaxine. How to know if this vaccine is completely safe and effective?
What is the main concern of experts?
Dr. Gagandeep Kang, one of the top vaccine scientists in the country, says that the regulatory process has led to confusion. If emergency approval has been given to covaxin, how will it be used in clinical trial mode? This has never happened before, how will it happen now? It would have known the impact and then giving emergency approval, there would be no problem.
They also say that the SII trials of Coveshield are being called Phase-2/3 trials. But it has everything that happens in phase-2 trials worldwide. That is, safety and immunogenicity are being seen in it, its effect is not being analyzed. If someone has asked how our approval differs from China and Russia, I have no answer.
What is the government's argument on the objections of experts?
Dr. Guleria states that there is no anti-viral drug available against coronavirus. As such, covaxin has been approved in the same way as remdesivir and hydroxychloroquine have been given limited approval.
He says cases have increased rapidly in Britain, the United States, and Europe. If we also have a fast case, then we also have to use covaxin as a back-up. It can be an effective weapon in preventing the spread of corona.
If there is no data regarding the effect of covaxin, Dr. Guleria says that at present, only the SII vaccine will be used more. When interim data from Covaxin's Phase-3 trials are revealed, it too will get approval like Covishield.
He says that caution will be maintained regarding the use of covaxin. It is not permitted to market the vaccine. It will be installed in trial mode only. That means its database will be maintained. Those who are vaccinated will have side-effects monitoring.
CUET UG Exam: The CUET-UG exam will be held again on July 19, NTA issued a notification; Doubt about the result
The National Examination Agency (NTA) has decided to conduct a re-examination on July 19 for more than a thousand CUET-UG candidates. These candidates belong to six states. According to NTA sources, a
MS Dhoni Retirement: Team India changed after the retirement of 'Mahi', second finisher not found; pair of broken 'kulcha'
Former India captain MS Dhoni (MS Dhoni) said goodbye to international cricket on 15 August 2020. On one hand, the whole country was immersed in the celebration of independence. At the same time,
The positivity rate in the country for the last 21 days is less than 10 percent, the recovery rate has increased to 95.43 percent.
The pace of corona has slowed down in India. In the last 24 hours, 70,421 new cases were reported while 3921 people have died due to infection. The lowest number of new cases have been reported after
Evlish Yadav: 'Bigg Boss OTT 2' winner Elvish Yadav broke his silence about his girlfriend, made a big disclosure on his love life
YouTuber Elvish Yadav is in the limelight after winning the trophy of 'Bigg Boss OTT 2'. Their demand is increasing day by day. Elvish went live on Insta where people joined him in record-breaking
Crowds enter madrassa in Karnataka on Dussehra: worshiped with slogans of Jai Shri Ram, 4 arrested; Home Minister said – it happened in misunderstanding
Some people participating in the Dussehra rally in the Bidar district of Karnataka barged into an old madrasa. Here these people raised slogans and also worshiped in a corner of the madrasa. In this
Indian Railways / IRCTC: Check before booking the passenger ticket, Railways has canceled many trains by May 31; See list
Indian Railways / IRCTC, the second wave of Corona epidemic continues in the country. Railways have canceled many trains during the Corona crisis. Indian Railways has been canceling a large number of
Maha Kumbh stampede: There will be a judicial inquiry into the accident, a three-member committee will investigate and submit a report, and compensation of Rs 25 lakh will be given
The Chief Minister ordered a judicial inquiry into the accident and constituted a three-member judicial inquiry commission. The chairman of this commission will be former judge Harsh Kumar, while
R Ashwin retired from international cricket, and followed the tradition of these legends including Dhoni.
India's veteran off-spinner Ravichandran Ashwin has announced his retirement. At the age of 38, Ashwin has announced his retirement from international cricket. He surprised the cricket world by
PM Modi Pithoragarh Visit: PM Modi is coming to Pithoragarh, preparations intensified; Picture of Jageshwar Dham will change
Prime Minister Narendra Modi is going to visit Uttarakhand soon. Preparations for PM Modi have intensified. The Prime Minister can reach Jageshwar before Pithoragarh. On Wednesday, the administration
DA hike up to 31 percent effective from July 1, separate orders will be issued for armed forces and railway employees
Dearness Allowance for Central Government employees has been increased from 28 percent to 31 percent of the basic pay with effect from July 1, 2021. This information has been given by the Ministry of
